Clinical Trials Directory

Trials / Completed

CompletedNCT05449717

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Epicentre · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis.

Detailed description

This prospective, observational cohort study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis from a hospital in Lankien, South Sudan.

Conditions

Timeline

Start date
2022-05-31
Primary completion
2025-04-11
Completion
2025-04-11
First posted
2022-07-08
Last updated
2025-04-24

Locations

1 site across 1 country: South Sudan

Source: ClinicalTrials.gov record NCT05449717. Inclusion in this directory is not an endorsement.

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan (NCT05449717) · Clinical Trials Directory